Analyst Signal

Eli Lilly and Company (LLY) is currently trading at $935.58. Based on 29 Wall Street analysts, the average target price is $1209.21, implying a 29.2% upside. The consensus recommendation is BUY.

LLY

Eli Lilly and Company

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$935.58

Avg Target

$1209.21

Based on 29 analysts

Analyst Recommendations

Buy (24)Hold (6)Sell (1)

Upside

+29.25%

Market Cap

$837.36B

Financial & Investment Metrics

Next Earnings Date
Apr 30, 2026D-27
P/E Ratio (TTM)40.82
Forward P/E22.24
P/B Ratio31.55
Dividend Yield0.67%
Return on Equity (ROE)101.16%
Operating Margin44.90%
Debt to Equity165.31
Beta (Volatility)0.43
52 Week Range$623.78 - $1133.95
LowCurrent: $935.58High

Insider Sentiment Index (Last 6 Months)

Buy vs Sell (Count)

Insider Buys: 61Insider Sells: 31

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
3/16/2026ALVAREZ RALPHDirectorStock Award(Grant) at price 989.12 per share.12
3/16/2026FYRWALD J. ERIKDirectorStock Award(Grant) at price 989.12 per share.10
3/16/2026SULZBERGER GABRIELLEDirectorStock Award(Grant) at price 989.12 per share.5
3/16/2026LUCIANO JUAN RDirectorStock Award(Grant) at price 989.12 per share.16
2/19/2026DOZIER ERICOfficerStock Gift at price 0.00 per share.481
2/17/2026ALVAREZ RALPHDirectorStock Award(Grant) at price 1036.05 per share.11
2/17/2026FYRWALD J. ERIKDirectorStock Award(Grant) at price 1036.05 per share.9
2/17/2026SULZBERGER GABRIELLEDirectorStock Award(Grant) at price 1036.05 per share.4
2/17/2026LUCIANO JUAN RDirectorStock Award(Grant) at price 1036.05 per share.15
2/13/2026ZAKROWSKI DONALD AChief Financial OfficerN/A184

Frequently Asked Questions

Q. What is the current target price and upside for LLY?

A. The current target price for Eli Lilly and Company is $1209.21, which implies a 29.2% upside from the current price of $935.58. This is based on the consensus of 29 Wall Street analysts.

Q. What is the current analyst recommendation for LLY?

A. Currently, there are 6 Strong Buy, 18 Buy, 6 Hold, 1 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying LLY stock recently?

A. Over the past 6 months, there have been 61 insider buys and 31 insider sells. This can be interpreted as a positive signal.

Other Promising Stocks in Healthcare

LLY (Eli Lilly and Company) Stock Analysis | Analyst Signal